Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine Added to Usual Treatment in Refractory Obsessive–Compulsive Disorder
IRCT20110918007582N2Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clonidine in obsessive compulsive disorder (OCD), sponsored by Isfahan University of Medical Sciences. Started Dec 2018; status: completed.
02
Drugs
clonidine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on IRCT20110918007582N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110918007582N2.